Charles Bailey

Dr. Charles Bailey is a Senior Research Fellow at the University of Sydney's Central Clinical School, Department of Medicine, and an affiliated researcher at the Centenary Institute of Cancer Medicine & Cell Biology. His work focuses on cancer biology, epigenetics, and molecular mechanisms underlying genetic diseases. Dr. Bailey leads projects investigating CTCF protein functions in cancer, alternative splicing regulation, and therapeutic targeting of cancer-related pathways.

Research Interests: Dr. Bailey's research spans cancer epigenetics (particularly CTCF and chromatin remodeling), gene therapy development, protein-protein interaction networks, and molecular mechanisms of tumor suppression. His work combines experimental models (mouse and cell cultures) with clinical data analysis to bridge basic science and translational medicine.

Recent Directions: His articles from 2023 highlight clinical trials for novel cancer drug combinations (e.g., olaparib/durvalumab) and mechanisms of embryo development. Earlier work revealed critical roles for CTCF in genome regulation, while 2022 studies advanced understanding of NuRD complex interactions and lens development pathways.

Grants & Awards: Recipient of multiple grants including Tour de Cure's Pioneering Research Awards (2023, 2022, 2021) and Cancer Council NSW support. Projects focus on exploiting genomic vulnerabilities in pancreatic/endometrial cancers and developing gene therapy delivery systems.

Collaborations: Active collaborations across Sydney's medical research community, including work with Prof. John Rasko on gene therapy vectors and Prof. Michelle Semsarian on heart disease mechanisms.